- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Study Finds a Promising treatment Option for Melasma
Dealing with severe or refractory melasma can be challenging for all concerned. A recent study suggests that 1064 nm Nd: YAG laser with a 650-microsecond pulse duration may be a useful laser modality in the treatment of melasma. The study findings were published in the Journal of Cosmetic Dermatology on November 11, 2021.
The effective treatment of melasma remains a challenge that necessitates a multifaceted approach that includes strict sun protection, bleaching creams, chemical peels, and laser therapy. Previous studies findings showed that 1064 nm Nd: YAG laser with a 650-microsecond pulse duration is safe for all skin types and more tolerable than conventional long-pulsed Nd: YAG lasers. To further examine, Dr Tanya Greywal and Dr Arisa Ortiz conducted a study and evaluated the safety and efficacy of 1064 nm Nd: YAG laser with a 650-microsecond pulse duration for the treatment of melasma.
In this conservative treatment protocol, the researchers included a total of 10 patients with the 1064 nm Nd: YAG laser with 650-microsecond pulse duration. They performed treatments every 2–4 weeks. The energy mode ranged from 3 to 4, which corresponds to a fluence of 11to 14J/cm2 with a 6mm spot size, and 3 passes were performed per treatment session.
Key findings of the study:
- Upon analysis, the researchers observed lightening of melasma occurred as early as 3 weeks post-treatment, with all subjects requiring several treatment sessions to achieve adequate resolution of their melasma.
- They noted that the majority of subjects experienced up to 25% improvement after two treatments, and an even more noticeable improvement after the 3rd treatment session.
- They reported no associated pain or discomfort.
The authors concluded, "Advantages of this laser modality include essentially no pain or downtime, lower risk of rebound, and the ability to safely treat all skin types with melasma. Therefore, the 1064 nm Nd: YAG laser with a 650-microsecond pulse duration serves as a treatment option for melasma."
For further information:
DOI: https://doi.org/10.1111/jocd.14558
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751